Ocular Therapeutix Inc.

About Ocular Therapeutix Inc.

Ocular Therapeutix is a company focused on transforming the treatment of retinal diseases with innovative therapies like AXPAXLI™. Their mission is to reduce the therapeutic burden on patients, helping more individuals stay on treatment to preserve vision long-term.

Products & Services

AXPAXLI™ (OTX-TKI):An investigational axitinib hydrogel administered by intravitreal injection, currently in Phase 3 clinical trials for wet Age-Related Macular Degeneration (AMD).

OTX-TIC:A product in the pipeline for retinal disease treatment, though specific details are not provided in the content.

Specialties

Retinal Disease Treatment Intravitreal Injection Therapies Innovative Drug Delivery Systems for Ophthalmology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 475000000 MR: - FA: approximately $475.0 million FAN: 475000000	D: 2025-09-30 FD: 2025-09-30	7 investors
2	RT: Private Placement T: - FT: Private Placement	A: 325000000 MR: - FA: $325.0 million FAN: 325000000	D: 2024-02-22 FD: 2024-02-22	10 investors
3	RT: Public Offering T: - FT: Public Offering	A: 115100000 MR: - FA: approximately $115.1 million FAN: 115100000	D: 2023-12-18 FD: 2023-12-18	6 investors
4	RT: Public Offering T: - FT: Public Offering	A: 100100000 MR: - FA: $100.1 million FAN: 100100000	D: 2023-12-13 FD: 2023-12-13	6 investors

Underwritten Public Offering Latest

2025-09-30

$475.0M

7 investors (Pro only)

Private Placement 2024-02-22

$325.0M

Public Offering 2023-12-18

$115.1M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Brown

Chief Medical Officer

A

Andrew A. Moshfeghi

Vice Chair, Clinical Affairs, Department of Ophthalmology

D

Diana Do

Vice Chair, Clinical Affairs

G

Glenn Jaffe

Chief of Vitreoretinal Service

S

SriniVas Sadda

Professor of Ophthalmology

S

Sobha Sivaprasad

Director, National Institute for Health and Care Research Clinical Research Facility

View 33 more team members with Pro

Unlock Full Team Directory

Recent News